Izraelska firma twierdzi, że doustna szczepionka COVID-19 jest w drodze
An oral vaccine could potentially allow for people to self vaccinate at home.
An Israeli-American pharmaceutical company is preparing to launch a Phase I clinical trial for what could become the world’s first oral COVID-19 vaccine.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company based on technology developed by Hadassah-University Medical Center, announced over the weekend a joint venture with Premas Biotech to develop a novel oral vaccine. Together they formed the company Oravax Medical Inc. The vaccine is based on Oramed’s “POD” oral delivery technology and Premas’s vaccine technology.
Więcej na ten temat: https://www.jpost.com/health-science/israeli-company-says-oral-covid-19-vaccine-on-its-way-662712
An oral vaccine could potentially allow for people to self vaccinate at home.
An Israeli-American pharmaceutical company is preparing to launch a Phase I clinical trial for what could become the world’s first oral COVID-19 vaccine.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company based on technology developed by Hadassah-University Medical Center, announced over the weekend a joint venture with Premas Biotech to develop a novel oral vaccine. Together they formed the company Oravax Medical Inc. The vaccine is based on Oramed’s “POD” oral delivery technology and Premas’s vaccine technology.
Więcej na ten temat: https://www.jpost.com/health-science/israeli-company-says-oral-covid-19-vaccine-on-its-way-662712
Moze jakis przelom?
Zaloguj się aby komentować